- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-PD-1/CD279
PD-1/CD279 Monoclonal Antibody for WB, IHC, IF-P, ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain, porc, rat, souris
Applications
WB, IHC, IF-P, ELISA
Conjugaison
Non conjugué
CloneNo.
4H4D1
N° de cat : 66220-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
66220-1-PBS cible PD-1/CD279 dans les applications de WB, IHC, IF-P, ELISA et montre une réactivité avec des échantillons Humain, porc, rat, souris
| Réactivité | Humain, porc, rat, souris |
| Hôte / Isotype | Mouse / IgG2b |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | PD-1/CD279 Protéine recombinante Ag12470 |
| Nom complet | programmed cell death 1 |
| Masse moléculaire calculée | 288 aa, 32 kDa |
| Poids moléculaire observé | 32 kDa, 47-55 kDa |
| Numéro d’acquisition GenBank | BC074740 |
| Symbole du gène | PD-1 |
| Identification du gène (NCBI) | 5133 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Programmed cell death 1 (PD-1, also known as CD279) is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a 288 amino acid (aa) type I transmembrane protein composed of one Ig superfamily domain, a stalk, a transmembrane domain, and an intracellular domain containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) as well as an immunoreceptor tyrosine-based switch motif (ITSM) (PMID: 18173375). PD-1 is expressed during thymic development and is induced in a variety of hematopoietic cells in the periphery by antigen receptor signaling and cytokines (PMID: 20636820). Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function (PMID: 19426218). It is critical for the regulation of T cell function during immunity and tolerance. Blockade of PD-1 can overcome immune resistance and also has been shown to have antitumor activity (PMID: 22658127; 23169436). The calculated molecular weight of PD-1 is 32 kDa. It has been reported that PD-1 is heavily glycosylated and migrates with an apparent molecular mass of 47-55 kDa on SDS-PAGE (PMID: 8671665; 17640856; 17003438).



































